Stocks · Health care · Biological Products, (No Diagnostic Substances)

Kalaris Therapeutics, Inc.

KLRS Clue Score19
United States Fiscal year ends December CIK 0001754068 Results filed 11 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Srinivas Akkaraju
20 May 2026
Director
Buy indirect
244,300
$4.83
$1.18M
Srinivas Akkaraju
18 Dec 2025
Director
Buy indirect
479,847
$10.42
$5.00M

What was left out

Form 4 filings counted 17
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 1,586,314
History held since 31 Jul 2020